Skip to main content
Loading

From target identification to portfolio decisions: How AI builds the evidence engine

11 Feb 2027
Target Identification
  • How can AI unify fragmented evidence into actionable insights?
  • How can we identify causal, therapeutically actionable targets?
  • Can genetics predict therapeutic direction, efficacy, and safety?
  • How can we bridge target validation and clinical success?
  • How can AI transform static prioritization into dynamic portfolio decisions?

Industry Expert
Shicheng Guo, Senior Director, Translational Genetics & Data Science - Arrowhead Pharmaceuticals